Pregled bibliografske jedinice broj: 1214335
Counteracting organophosphate-induced toxicity by improved bioscavenging capacity of BChE and damage prevention at cell level
Counteracting organophosphate-induced toxicity by improved bioscavenging capacity of BChE and damage prevention at cell level // Journal of Neurochemistry. 2022 ; 162(Suppl. 1)
Honolulu (HI), Sjedinjene Američke Države, 2022. str. 58-59 doi:10.1111/jnc.15674 (poster, međunarodna recenzija, sažetak, znanstveni)
CROSBI ID: 1214335 Za ispravke kontaktirajte CROSBI podršku putem web obrasca
Naslov
Counteracting organophosphate-induced toxicity
by improved bioscavenging capacity of BChE and damage
prevention at cell level
Autori
Čadež, Tena ; Zandona, Antonio ; Katalinić, Maja ; Kovarik, Zrinka
Vrsta, podvrsta i kategorija rada
Sažeci sa skupova, sažetak, znanstveni
Izvornik
Journal of Neurochemistry. 2022 ; 162(Suppl. 1)
/ - , 2022, 58-59
Skup
ISN-APSN 2022 Meeting
Mjesto i datum
Honolulu (HI), Sjedinjene Američke Države, 28.08.2022. - 01.09.2022
Vrsta sudjelovanja
Poster
Vrsta recenzije
Međunarodna recenzija
Ključne riječi
Cyclosarin, butyrylcholesterase, pyridinium oximes, neuroblastoma, bioscavenging
Sažetak
The phosphylation of acetylcholinesterase (AChE), a pivotal enzyme in hydrolysis of the neurotransmitter acetylcholine, by nerve agents (NAs) still has no adequate or fully efficient medical countermeasures. Furthermore, oxime antidotes known for their nucleophilic properties have limited potency in the reactivation of phosphylated AChE in the central nervous system (CNS), so even after survival, long- term effects of poisoning could occur. However, the AChE related enzyme butyrylcholinesterase (BChE), typically present in the blood, serves as bioscavenger of OPs, before they reach the crucial AChE in CNS. In our study, we wanted to investigate with a combination of in silico, in vitro, and ex vivo methods, the feasibility of an approach to develop a safe bioscavenger of NAs, based on the oxime-assisted reactivation of BChE. Firstly, we identified a promising reactivator of cyclosarin- inhibited BChE as a model system with no impact on the viability of neuroblastoma cells upon 4-hour treatment. Herein, the efficient oxime-assisted catalytic BChE degradation of cyclosarin was demonstrated ex vivo. This pair was then applied to OP-treated cells and, as the result shows, it acted by, protecting cells’ homeostasis by preserving from 50% to nearly 100% of neural cells. The most significant result was obtained if the oxime and BChE pair were applied to cells before exposure to cyclosarin or in other words, as pretreatment. This result is in accordance with ex vivo effects determined in the whole blood showing up to 80% of restored phosphylated cholinesterase activity within two minutes. In conclusion, our findings showed that an antidote should act on two levels—on cholinesterase reactivity and prevention of the long- term effects of poisoning.
Izvorni jezik
Engleski
Znanstvena područja
Kemija, Temeljne medicinske znanosti, Farmacija
POVEZANOST RADA
Projekti:
IP-2018-01-7683 - Analiza interakcija butirilkolinesteraze s novim inhibitorima i reaktivatorima (AnalyseBChE) (Kovarik, Zrinka, HRZZ - 2018-01) ( CroRIS)
Ustanove:
Institut za medicinska istraživanja i medicinu rada, Zagreb